KTTAW Pasithea Therapeutics Corp.

NEUTRAL Impact: 2/10 8-K
Horizon weeks Filed May 4, 2026 Processed 19d 5h ago SEC 0001213900-26-051681
8-K context-dependent: Items 5.02, 7.01
Latest settled — T+5d
KTTAW ▲ 0.00% at T+5d
NEUTRAL call ✗ call lost 0.00% · α vs SPY -1.98% · entry $0.0109 → $0.0109
Next anchor: T+20d in 9d
Last close $0.0109 (close May 22) · +0.00% from $0.0109 entry
Entry anchored
May 4, 2026
via day open
T+1d
0.00%
call 0.00% · α -1.38%
$0.0109
settled 19d ago
T+5d
0.00%
call 0.00% · α -1.98%
$0.0109
settled 13d ago
T+20d
—
call — · α —
—
in 9d
T+60d
—
call — · α —
—
in 2mo

Price Chart

Loading chart...

Executive Summary

Pasithea Therapeutics appointed Dr. Kartik Krishnan as Chief Medical Officer effective May 1, 2026, and granted substantial stock options to executives, employees, and directors at $0.841 per share. This is a routine organizational change with no financial results or guidance provided.

Actionable Insight

Monitor upcoming trial data for PAS-004 (NF1 Phase 1/1b) as the key catalyst; the CMO appointment adds relevant MEK inhibitor experience but provides no immediate trading signal.

Key Facts

  • Kartik Krishnan appointed CMO effective May 1, 2026; base salary $500k plus up to 40% annual bonus.
  • Stock option grants: CEO 1,756,069 shares; CFO 1,129,323; CMO 1,129,323; employees 1,239,323; directors 611,132 total. All at $0.841 exercise price.
  • Options vest 33% year 1, remaining quarterly over 2 years; full vest on change of control.
  • No departures, financial results, or guidance were disclosed.

Financial Impact

No direct financial impact disclosed; option grants are standard compensation.

dilution

Risk Factors

  • Potential dilution from option exercises (up to ~5.86M shares).
  • Clinical trial risks for PAS-004; no efficacy data yet.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001213900-26-051681
Document: ea0288864-8k_pasithea.htm0001213900-26-051681
Document: ea028886401ex99-1.htm0001213900-26-051681
Document: 0001213900-26-051681-index-headers.html0001213900-26-051681
Document: 0001213900-26-051681-index.html0001213900-26-051681
Document: 0001213900-26-051681.txt0001213900-26-051681

US Market Status

Market Closed — Opens Tue (35h 12m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access